A case of residual non-small cell lung cancer cells coexisting with newly developed small cell lung cancer cells in ascitic fluid after chemotherapy for non-small cell lung cancer

Ann Lab Med. 2014 Mar;34(2):163-5. doi: 10.3343/alm.2014.34.2.163. Epub 2014 Feb 13.

Authors

Sang Hyuk Park¹, Hyun-Sook Chi², Young Jin Kim³, Young-Uk Cho², Seongsoo Jang², Chan-Jeoung Park², Sang-We Kim⁴

Affiliations

¹ Department of Laboratory Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea.
² Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
³ Department of Laboratory Medicine, Kyung Hee University School of Medicine, Seoul, Korea.
⁴ Department of Oncology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / therapeutic use
Ascitic Fluid / cytology*
Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Non-Small-Cell Lung / pathology
ErbB Receptors / genetics
Gefitinib
Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / drug therapy
Lung Neoplasms / pathology
Lymphatic Metastasis
Male
Middle Aged
Mutation
Neoplasm Staging
Quinazolines / therapeutic use
Small Cell Lung Carcinoma / diagnosis*
Small Cell Lung Carcinoma / pathology
Tomography, X-Ray Computed

Substances

Antineoplastic Agents
Quinazolines
EGFR protein, human
ErbB Receptors
Gefitinib